Latest News
Orca, an independent data, research and analysis provider on the UK peer-to-peer (P2P) lending market, has launched a platform aimed at helping financial advisers and sophisticated investors visualise and take advantage of opportunities within the P2P market.
The platform, offering standardised metrics to compare P2P investments, will allow users to perform in-depth due diligence on P2P investments, benchmark them in a way they would traditional asset classes, and hence make risk-adjusted, informed investment decisions or recommendations.
The P2P market has seen tremendous growth in the past two years, increasing by 40 per cent in 2016. It is estimated that
Panasonic Corporation is to establish a new company, Panasonic Ventures, in April 2017, which will be based in California and invest in start-up companies mainly in the US, with initial investments of around USD100 million.
Panasonic has invested in Silicon Valley start-ups with cutting-edge technologies for nearly 20 years since 1998.
As a member of the venture community, the company has been helping these firms grow by providing a wide array of in-house technologies and human resources.
Going forward, Panasonic Ventures, with new external venture capitalists, will spearhead Panasonic's investments in start-ups that have unique business models or
Omnes Capital, with the support of co-investors Capital Transmission (Banque Cantonale de Genève) and Bpifrance, has acquired a stake in Groupe RGF alongside buyer Pascal Daviet as part of a management buy-in (MBI).
Joël Béraldin, director and 100 per cent shareholder in the company, has sold all of his shares and has acquired minority stakes in the new transaction.
Based in Pratz, the group specialises in the design and production of plastic and/or metal technical small parts in niche markets. Groupe RGF covers the entire production chain, including design, creation of moulds, injection, undercutting, overmoulding and automated assembly. The
O’Melveny has represented Berkeley Research Group, a global strategic advisory and consulting firm, in connection with its USD62.5 million investment from affiliates of Endeavour Capital.
Proceeds from the investment will be used to provide additional working capital to support BRG’s continued expansion across its core service lines.
The O’Melveny team was led by partners Sean Monroe and Chuck Baker, along with associates Alexandra Piarino and Evie Whiting. Partner Robert Blashek provided tax guidance.
CVC Capital Partners Fund VI has completed the acquisition of Corialis (Core Innovative Aluminium Integrated Solutions), a European manufacturer of aluminium profiles and systems, supplying door, window and conservatory manufacturers in both the new construction and refurbishment markets, from Advent International.
The transaction values Corialis at an enterprise value of approximately EUR1 billion.
Steven Buyse, partner at CVC Capital Partners, says: “We are delighted to partner with Johan and his talented leadership team to further build out this highly successful business. Consistently delivering high-quality aluminium profile systems with industry-leading lead times and service levels has led to a fantastic
While the current M&A environment is still trending to be more favourable to sellers as has been the case over the past two years, there are indications to suggest that certain terms are slightly less seller favourable than in 2015.
This is according to law firm Seyfarth Shaw’s fourth edition of its Middle-Market M&A SurveyBook of Key M&A Deal Terms, which analyses over 150 middle-market (<USD1 billion) publicly available private target acquisition agreements signed in 2016.
The Survey focuses on the key deal terms comprising the “indemnity package” often included in private target acquisition agreements to address the issue
Ripjar has secured an additional GBP3.75 million (USD4.5 million) in capital to bring its data analytics platform to more customers across the globe.
Just eight months after announcing its first institutional funding, Ripjar has plans to further accelerate its pace of growth.
Since receiving its initial investment from Winton Ventures, the team has more than doubled in size in both its Cheltenham and London offices.
Ripjar was founded in 2012 by engineers and data scientists from the UK Government Communications Headquarters (GCHQ) in Cheltenham.
Ripjar’s next-generation Strategic Intelligence Platform (Ripjar SI) fuses deep learning technology, advanced analytics
NVM Private Equity has invested GBP3 million in Intelling Limited, a communications business which provides customer services support for companies such as Telefonica and Missguided.
The company has a number of growth opportunities, including new geographies and markets, and the funding from NVM will accelerate the development of new business streams and help strengthen the growth of Intelling’s core activity.
Intelling offers a range of inbound and outbound telemarketing and customer care services, specialising in the business to consumer market. Headquartered in Manchester with additional premises in Belfast and Burnley, the company currently has approximately 400 staff and has
Maranon Capital has appointed Kyle Smith and Brian Pearl as portfolio analysts.
In this role, they will primarily be working with Maranon’s investment and loan operations teams on portfolio management activities.
Prior to joining Maranon, Smith was a commercial credit analyst at MB Financial Bank.
Pearl was previously at PricewaterhouseCoopers, where he was an assurance associate.
Proveca, a European paediatric speciality pharmaceutical company, has raised GBP4 million to fund the commercial launch of Sialanar and the development and commercialisation of its paediatric product portfolio.
Sialanar is a treatment for chronic pathological drooling in children, launched in the UK by Proveca, to be followed by the rest of Europe.
The investment was led by Catapult Ventures, managers of the GM&C Life Sciences Fund, alongside Kreos Capital, a European provider of growth debt financing.
The investment comes soon after the EU-wide PUMA (Paediatric Use Marketing Authorisation) regulatory approval of Sialanar (glycopyrronium, oral solution) for the symptomatic
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
